Fundz

IMUNON Appoints Dr. Douglas V. Faller as Chief Medical Officer

PUBLIC · IMNNFeb 10, 2025

Position

Chief Medical Officer

Company

IMUNON

Douglas V. Faller
dfaller@imunon.com
LawrencevilleBiotechnologyHealthcare

Description

IMUNON, Inc has announced the appointment of Dr. Douglas V Faller, MD, PhD, as chief medical officer. Dr Faller will lead the company’s clinical strategy, specifically focusing on advancing its lead program IMNN-001 for the treatment of newly diagnosed advanced ovarian cancer.

Quick answer

IMUNON Appoints Dr. Douglas V. Faller as Chief Medical Officer (February 10, 2025). IMUNON is based in Lawrenceville, New Jersey, United States.

Who is the new Chief Medical Officer at IMUNON?
IMUNON named Douglas V. Faller Chief Medical Officer, announced February 10, 2025.
What did IMUNON announce on February 10, 2025?
IMUNON, Inc has announced the appointment of Dr. Douglas V Faller, MD, PhD, as chief medical officer. Dr Faller will lead the company’s clinical strategy, specifically focusing on advancing its lead program IMNN-001 for the treatment of newly diagnosed advanced ovarian cancer.
What does IMUNON do?
IMUNON is a clinical-stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the body’s natural mechanisms to generate safe, effective and durable responses across a broad...
Where is IMUNON based?
IMUNON is based in Lawrenceville, New Jersey, United States.
Which similar companies made leadership changes around the same time?
Lakewood-Amedex, Inc. (February 12, 2025), Sonnet BioTherapeutics Holdings (February 13, 2025), Terns Pharmaceuticals (February 25, 2025) and Climb Bio, Inc. (February 25, 2025) also announced leadership changes within 45 days of IMUNON.

Source: Fundz verified event record.

Other recent leadership changes in Healthcare and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at IMUNON, and when

A new leader at IMUNON brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day IMUNON raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at IMUNON, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at IMUNON. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

IMUNON

Location

Lawrenceville, New Jersey, United States

About

IMUNON is a clinical-stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the body’s natural mechanisms to generate safe, effective and durable responses across a broad array of human diseases, constituting a differentiating approach from conventional therapies. IMUNON is developing its non-viral DNA technology across its modalities. The first modality, TheraPlas®, is developed for the gene-based delivery of cytokines and other therapeutic proteins in the treatment of solid tumors where an immunological approach is deemed promising. The second modality, PlaCCine®, is developed for the gene delivery of viral antigens that can elicit a strong immunological response.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment IMUNON changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Stacy
Likely contact at this company
••••••••@••••••••

See Stacy's verified email →

Johan
Likely contact at this company
••••••••@••••••••

See Johan's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for IMUNON's next move

Learn about Strategic plan

IMUNON changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.